ALQA : Summary for Alliqua BioMedical, Inc. - Yahoo Finance

U.S. Markets closed

Alliqua BioMedical, Inc. (ALQA)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.64-0.04 (-5.88%)
At close: 4:00PM EDT
People also watch
CBYLALIMAKERBLPHADMP
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.68
Open0.68
Bid0.60 x 3000
Ask0.68 x 1000
Day's Range0.60 - 0.68
52 Week Range0.45 - 1.48
Volume296,778
Avg. Volume387,754
Market Cap22.47M
Beta1.02
PE Ratio (TTM)-0.63
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube4 hours ago

    ETFs with exposure to Alliqua BioMedical, Inc. : March 27, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Alliqua BioMedical, Inc. Here are 5 ETFs with the largest exposure to ALQA-US. Comparing the performance and risk of Alliqua BioMedical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Ultragenyx's Seizure Candidate UX007 Fails in Phase II Study
    Zacks4 days ago

    Ultragenyx's Seizure Candidate UX007 Fails in Phase II Study

    Ultragenyx Pharmaceutical Inc. (RARE) recently announced that its pipeline candidate UX007 (triheptanoin) failed to meet the primary endpoint in a phase II study evaluating it for the treatment of patients with Glut1 DS with seizures.

  • Alliqua BioMedical, Inc. :ALQA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube6 days ago

    Alliqua BioMedical, Inc. :ALQA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis Alliqua BioMedical, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Alliqua BioMedical, Inc. – Merit Medical Systems, Inc., STERIS Plc, Endologix, Inc., ICU Medical, Inc., C. R. Bard, Inc., Unilife Corporation and Antares Pharma, Inc. (MMSI-US, STE-US, ELGX-US, ... Read more (Read more...)